Joseph L Kuti Selected Research

Anti-Bacterial Agents (Antibiotics)

1/2022	Pharmacodynamic Thresholds for Beta-Lactam Antibiotics: A Story of Mouse Versus Man.
1/2021	Contemporary analysis of ETEST for antibiotic susceptibility and minimum inhibitory concentration agreement against Pseudomonas aeruginosa from patients with cystic fibrosis.
12/2019	Pharmacokinetics of Telavancin in Adult Patients with Cystic Fibrosis during Acute Pulmonary Exacerbation.
10/2019	Application of the Hartford Hospital Nomogram for Plazomicin Dosing Interval Selection in Patients with Complicated Urinary Tract Infection.
10/2019	Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
1/2019	In Vitro Pharmacodynamics of a Novel Ceftibuten-Clavulanate Combination Antibiotic against Enterobacteriaceae.
1/2019	Is One Sample Enough? β-Lactam Target Attainment and Penetration into Epithelial Lining Fluid Based on Multiple Bronchoalveolar Lavage Sampling Time Points in a Swine Pneumonia Model.
12/2018	Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department.
10/2018	Variability in Emergency Medicine Provider Decisions on Hospital Admission and Antibiotic Treatment in a Survey Study for Acute Bacterial Skin and Skin Structure Infections: Opportunities for Antimicrobial Stewardship Education.
5/2016	Antibiotic Utilization and Opportunities for Stewardship Among Hospitalized Patients With Influenza Respiratory Tract Infection.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joseph L Kuti Research Topics

Disease

65	Infections 01/2022 - 01/2002
19	Body Weight (Weight, Body) 12/2019 - 08/2005
15	Critical Illness (Critically Ill) 07/2022 - 04/2009
14	Pneumonia (Pneumonitis) 11/2021 - 12/2005
12	Ventilator-Associated Pneumonia 09/2019 - 02/2009
10	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 04/2004
8	Sepsis (Septicemia) 01/2020 - 07/2005
7	Intraabdominal Infections 10/2019 - 08/2005
6	Wounds and Injuries (Trauma) 01/2022 - 11/2008
6	Diabetic Foot 01/2022 - 09/2011
5	Bacterial Pneumonia 01/2020 - 09/2011
4	Wound Infection (Wound Infections) 01/2022 - 01/2005
4	Healthcare-Associated Pneumonia 01/2019 - 10/2005
4	Respiratory Tract Infections (Respiratory Tract Infection) 05/2016 - 05/2007
4	Soft Tissue Infections 12/2014 - 01/2005
4	Peritonitis 10/2010 - 01/2005
3	Bacterial Infections (Bacterial Infection) 04/2021 - 05/2016
3	Communicable Diseases (Infectious Diseases) 01/2020 - 02/2009
3	Urinary Tract Infections (Urinary Tract Infection) 01/2020 - 01/2019
3	Pseudomonas Infections 01/2018 - 11/2005
3	Superinfection 07/2013 - 02/2009
3	Meningitis 06/2007 - 01/2006
2	Bacteremia 01/2019 - 03/2007
2	Febrile Neutropenia 02/2016 - 10/2012
2	Mycoses (Diseases, Fungus) 10/2010 - 01/2004
2	Otitis Media 01/2008 - 01/2008
1	Epilepsy (Aura) 12/2021
1	Stenotrophomonas maltophilia bacteremia 09/2021
1	AIDS-Related Complex (ARC) 04/2021
1	Overweight 01/2017
1	Human Influenza (Influenza) 05/2016
1	Clostridium Infections 02/2016
1	Chronic Bronchitis 05/2015
1	Neutropenia 03/2015
1	Fever (Fevers) 03/2015

Drug/Important Bio-Agent (IBA)

43	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 08/2004
19	Meropenem (Merrem)FDA LinkGeneric 09/2019 - 04/2004
18	Pharmaceutical PreparationsIBA 01/2022 - 09/2002
15	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 09/2015 - 04/2002
13	Cefepime (Maxipime)FDA LinkGeneric 07/2022 - 07/2005
12	Vancomycin FDA LinkGeneric 11/2021 - 03/2007
10	CreatinineIBA 04/2021 - 08/2005
9	Carbapenems (Carbapenem Antibiotics)IBA 12/2021 - 08/2004
8	beta-LactamsIBA 01/2022 - 01/2005
7	tazobactam drug combination ceftolozaneIBA 04/2021 - 09/2015
7	Daptomycin FDA Link 01/2020 - 01/2005
6	Ceftazidime (Fortum)FDA LinkGeneric 01/2020 - 07/2005
6	Tigecycline (Tygacil)FDA Link 09/2019 - 01/2005
6	Linezolid (Zyvox)FDA Link 01/2017 - 01/2005
5	Levofloxacin (Levaquin)FDA Link 12/2021 - 04/2007
5	telavancin FDA Link 11/2021 - 03/2007
5	Colistin (Coly-Mycin)FDA Link 09/2019 - 01/2006
4	plazomicinIBA 01/2020 - 01/2019
4	LactamsIBA 01/2020 - 02/2014
4	AminoglycosidesIBA 01/2020 - 01/2006
4	Piperacillin FDA LinkGeneric 01/2019 - 08/2005
4	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 12/2014 - 04/2007
4	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 02/2008 - 01/2005
3	Tazobactam FDA LinkGeneric 04/2021 - 08/2005
3	Imipenem FDA Link 01/2019 - 10/2005
3	beta-Lactamases (beta-Lactamase)IBA 01/2008 - 11/2006
2	ceftolozaneIBA 04/2021 - 01/2019
2	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2019 - 01/2014
2	Amikacin (A.M.K)FDA LinkGeneric 01/2019 - 01/2018
2	Cefazolin (Ancef)FDA LinkGeneric 01/2017 - 12/2014
2	beta Lactam AntibioticsIBA 10/2016 - 01/2005
2	Ceftaroline FDA Link 12/2014 - 01/2014
2	Methicillin (Metin)FDA Link 12/2014 - 12/2014
2	Ertapenem (Invanz)FDA Link 11/2014 - 04/2007
2	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2014 - 01/2006
2	Dihydrotachysterol (AT 10)IBA 01/2014 - 12/2010
2	Doripenem FDA Link 05/2013 - 10/2012
2	Anidulafungin FDA Link 10/2010 - 12/2009
2	CoagulaseIBA 02/2008 - 01/2005
2	dalbavancinIBA 05/2007 - 01/2005
1	omadacyclineIBA 01/2022
1	Thymidine Monophosphate (TMP)IBA 01/2022
1	Minocycline (Cyclops)FDA LinkGeneric 01/2022
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2022
1	Valproic Acid (Depakote)FDA LinkGeneric 12/2021
1	CefiderocolIBA 09/2021
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2020
1	ceftazidime drug combination avibactamIBA 01/2020
1	avibactamIBA 01/2020
1	eravacyclineIBA 10/2019
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 01/2019
1	relebactamIBA 01/2019
1	Ceftibuten (Cedax)FDA Link 01/2019
1	Anti-Infective Agents (Microbicides)IBA 01/2019
1	tedizolidIBA 01/2018
1	FidaxomicinIBA 02/2016
1	AmpC beta-lactamasesIBA 11/2014

Therapy/Procedure

27	Therapeutics 01/2020 - 08/2004
7	Length of Stay 05/2010 - 06/2004
6	Catheters 01/2022 - 05/2007
3	Mechanical Ventilators (Ventilator) 01/2020 - 09/2011
2	Drug Therapy (Chemotherapy) 01/2018 - 01/2005
2	Critical Care (Surgical Intensive Care) 04/2009 - 02/2009
1	Extracorporeal Membrane Oxygenation 07/2022
1	Antibiotic Prophylaxis 01/2017